Celldex Therapeutics Inc · Operating Cash Flow (Statement)

Latest reported-$235.57Mperiod endingJun 30, 2026

CLDX TTM Cash from Operations (-$3.40M → -$235.57M)

TTM operating cash flow (statement)

High-resolution chart · PNG

CLDX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Celldex Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-12,409,900
Mar 31, 2001	-10,898,300
Dec 31, 2000	-4,431,900
Sep 30, 2000	-5,383,800
Jun 30, 2000	-5,268,700
Mar 31, 2000	-4,942,200
Dec 31, 1999	-8,539,100
Sep 30, 1999	-8,400,000
Jun 30, 1999	-9,800,000
Mar 31, 1999	-9,400,000
Dec 31, 1998	-8,900,000
Sep 30, 1998	-9,900,000
Jun 30, 1998	-8,100,000
Mar 31, 1998	-7,500,000
Dec 31, 1997	-7,700,000
Sep 30, 1997	-7,500,000
Jun 30, 1997	-8,000,000
Mar 31, 1997	-9,100,000
Dec 31, 1996	-9,700,000
Sep 30, 1996	-6,900,000
Jun 30, 1996	-7,700,000
Mar 31, 1996	-7,500,000
Dec 31, 1995	-7,900,000
Sep 30, 1995	-11,500,000
Jun 30, 1995	-10,200,000
Mar 31, 1995	-10,200,000
Dec 31, 1994	-9,100,000
Sep 30, 1994	-7,400,000
Jun 30, 1994	-6,600,000
Mar 31, 1994	-5,900,000
Dec 31, 1993	-5,500,000
Sep 30, 1993	-6,000,000
Jun 30, 1993	-5,900,000
Mar 31, 1993	-5,500,000
Oct 31, 1992	-4,400,000
Jul 31, 1992	-4,400,000
Apr 30, 1992	-4,100,000
Jan 31, 1992	-2,900,000
Oct 31, 1991	-3,400,000
Jul 31, 1991	-3,500,000
Apr 30, 1991	-3,000,000
Jan 31, 1991	-1,100,000